EPISODE · Mar 25, 2026 · 39 MIN
Why can't Big Pharma slay Antibiotic Resistance?
from How Science Speaks to Power · host Roger Jacobs
Big Pharma makes billions from medicine you may take for life, but their profit from marketing a drug you may need once in your life is too low to justify the effort. Science is coming up with many new antibiotic candidates , and we really need them- because superbugs are resistant to the antibiotics we already have. Our current system of funding new drugs is not working for us.We talk to researchers and patients about the obstacles and new ways forward to cure sepsis and develop drugs of high social value.
Embed this episode
NOW PLAYING
Why can't Big Pharma slay Antibiotic Resistance?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.